Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs EMMESSAR CHM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES PHARMA SCIENCE EMMESSAR CHM STRIDES PHARMA SCIENCE/
EMMESSAR CHM
 
P/E (TTM) x 46.5 24.8 187.2% View Chart
P/BV x 6.5 2.9 224.2% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 STRIDES PHARMA SCIENCE   EMMESSAR CHM
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-24
EMMESSAR CHM
Mar-24
STRIDES PHARMA SCIENCE/
EMMESSAR CHM
5-Yr Chart
Click to enlarge
High Rs83848 1,757.4%   
Low Rs28821 1,364.5%   
Sales per share (Unadj.) Rs440.81.1 39,713.4%  
Earnings per share (Unadj.) Rs-16.21.5 -1,077.5%  
Cash flow per share (Unadj.) Rs7.91.7 463.4%  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs231.014.8 1,560.1%  
Shares outstanding (eoy) m91.905.00 1,838.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.330.9 4.1%   
Avg P/E ratio x-34.822.9 -151.9%  
P/CF ratio (eoy) x71.720.3 353.6%  
Price / Book Value ratio x2.42.3 105.0%  
Dividend payout %-15.50-   
Avg Mkt Cap Rs m51,740172 30,109.1%   
No. of employees `000NANA-   
Total wages/salary Rs m7,51110 78,487.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m40,5116 729,932.3%  
Other income Rs m49820 2,502.5%   
Total revenues Rs m41,01025 161,011.9%   
Gross profit Rs m3,683-11 -34,073.5%  
Depreciation Rs m2,2071 225,186.7%   
Interest Rs m3,1440 31,444,500.0%   
Profit before tax Rs m-1,1698 -14,384.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3161 50,142.9%   
Profit after tax Rs m-1,4858 -19,804.5%  
Gross profit margin %9.1-194.7 -4.7%  
Effective tax rate %-27.07.7 -348.6%   
Net profit margin %-3.7135.1 -2.7%  
BALANCE SHEET DATA
Current assets Rs m29,69069 43,298.8%   
Current liabilities Rs m28,7935 543,256.4%   
Net working cap to sales %2.21,140.1 0.2%  
Current ratio x1.012.9 8.0%  
Inventory Days Days619 677.2%  
Debtors Days Days103147 70.2%  
Net fixed assets Rs m26,03419 136,232.9%   
Share capital Rs m91950 1,839.5%   
"Free" reserves Rs m20,30624 84,396.2%   
Net worth Rs m21,22574 28,674.3%   
Long term debt Rs m6,7150-   
Total assets Rs m55,72488 63,546.7%  
Interest coverage x0.6814.0 0.1%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.70.1 1,148.7%   
Return on assets %3.08.6 34.8%  
Return on equity %-7.010.1 -69.1%  
Return on capital %7.111.0 64.3%  
Exports to sales %49.746.0 107.9%   
Imports to sales %00-   
Exports (fob) Rs m20,1313 786,365.2%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m21,0853 823,626.6%   
Fx outflow Rs m7570-   
Net fx Rs m20,3283 794,054.7%   
CASH FLOW
From Operations Rs m7,0116 108,692.2%  
From Investments Rs m-1,503-6 23,330.7%  
From Financial Activity Rs m-6,933NA-  
Net Cashflow Rs m-1,4250 -14,248,100.0%  

Share Holding

Indian Promoters % 25.8 59.5 43.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 48.3 0.2 24,165.0%  
FIIs % 30.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.2 40.5 183.2%  
Shareholders   96,009 6,936 1,384.2%  
Pledged promoter(s) holding % 49.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES PHARMA SCIENCE With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on STRIDES PHARMA SCIENCE vs EMMESSAR CHM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

STRIDES PHARMA SCIENCE vs EMMESSAR CHM Share Price Performance

Period STRIDES PHARMA SCIENCE EMMESSAR CHM S&P BSE HEALTHCARE
1-Day 0.04% -4.82% 1.23%
1-Month -3.16% -7.72% -0.24%
1-Year 209.13% 64.50% 43.62%
3-Year CAGR 46.48% 19.46% 20.35%
5-Year CAGR 30.17% 32.60% 26.24%

* Compound Annual Growth Rate

Here are more details on the STRIDES PHARMA SCIENCE share price and the EMMESSAR CHM share price.

Moving on to shareholding structures...

The promoters of STRIDES PHARMA SCIENCE hold a 25.8% stake in the company. In case of EMMESSAR CHM the stake stands at 59.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of STRIDES PHARMA SCIENCE and the shareholding pattern of EMMESSAR CHM.

Finally, a word on dividends...

In the most recent financial year, STRIDES PHARMA SCIENCE paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of -15.5%.

EMMESSAR CHM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of STRIDES PHARMA SCIENCE, and the dividend history of EMMESSAR CHM.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.